Figure 2From: Rationale and design of the oral HEMe iron polypeptide Against Treatment with Oral Controlled Release Iron Tablets trial for the correction of anaemia in peritoneal dialysis patients (HEMATOCRIT trial) Trial schedule (all tests are ordered as per routine clinical practice).Back to article page